The University of Chicago Header Logo

Connection

Mark Kozloff to Colonic Neoplasms

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Colonic Neoplasms.
Mark Kozloff
Connection Strength
0.263
Colonic Neoplasms
  1. Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study. Future Oncol. 2022 Sep; 18(27):3011-3020.
    View in: PubMed
    Score: 0.137
  2. Personalized colon cancer care in 2010. Semin Oncol. 2011 Apr; 38(2):284-308.
    View in: PubMed
    Score: 0.062
  3. Cutaneous eruption related to human epidermal growth factor receptor inhibitors in stage IV colon cancer. Clin J Oncol Nurs. 2009 Oct; 13(5):491-3.
    View in: PubMed
    Score: 0.056
  4. Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):869-72.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.